MARDX LLYME DISEASE EIA (IGG & IGM) TEST SYSTEM

Reagent, Borrelia Serological Reagent

MARDX DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Mardx Diagnostics, Inc. with the FDA for Mardx Llyme Disease Eia (igg & Igm) Test System.

Pre-market Notification Details

Device IDK892206
510k NumberK892206
Device Name:MARDX LLYME DISEASE EIA (IGG & IGM) TEST SYSTEM
ClassificationReagent, Borrelia Serological Reagent
Applicant MARDX DIAGNOSTICS, INC. 847 JERUSALEM RD. Scotch Plains,  NJ  07076
ContactArthur Markovits
CorrespondentArthur Markovits
MARDX DIAGNOSTICS, INC. 847 JERUSALEM RD. Scotch Plains,  NJ  07076
Product CodeLSR  
CFR Regulation Number866.3830 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-04-03
Decision Date1989-08-15

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05391516746618 K892206 000
05391516746601 K892206 000
05391516746304 K892206 000
05391516746298 K892206 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.